Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 · New England Journal of Medicine · 6,029 citations
https://doi.org/10.1056/nejmoa1812389
E
Eri Kato
Kyoto University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
97
Papers
12.6K
Citations
21
h-index
33
i10-index
Eri Kato is an academic researcher from Kyoto University. The author has contributed to research in topics: Diabetes Treatment and Management & Acute Myocardial Infarction Research & Heart Failure Treatment and Management. The author has an h-index of 21, co-authored 83 publications.
ORCID: 0000-0001-6484-7743Papers by this author
worksJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
2025 · Circulation Journal · 98 citations
https://doi.org/10.1253/circj.cj-25-0002
Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis
2019 · BMC Musculoskeletal Disorders · 44 citations
https://doi.org/10.1186/s12891-019-2418-2
Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction
2021 · PLoS ONE · 36 citations
https://doi.org/10.1371/journal.pone.0259268
Deep Learning for Cardiac Overload Estimation ― Predicting B-Type Natriuretic Peptide (BNP) Levels From Heart Sounds and Electrocardiogram ―
2025 · Circulation Journal · 7 citations
https://doi.org/10.1253/circj.cj-25-0098
Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting Stents
2021 · JACC Asia · 5 citations
https://doi.org/10.1016/j.jacasi.2021.08.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat